Ascertaining instances of neuroleptic malignant syndrome in a secondary mental healthcare electronic medical records database: The SLAM BRC Case Register

Therapeutic Advances in Psychopharmacology

Volumn 2, Issue 2, 2012, Pages 75-83

  Chang, Chin Kuo ^a   Harrison, Simon ^a   Lee, William ^a   Taylor, David ^a   Stewart, Robert ^a  

^a NONE

Author keywords

antipsychotics; creatine kinase; diagnostic criteria; extrapyramidal syndrome; neuroleptic malignant syndrome; side effect

Indexed keywords

CREATINE KINASE;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; CONSCIOUSNESS DISORDER; ELECTRONIC MEDICAL RECORD; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CARE; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL; PSYCHIATRIST; RIGIDITY; UNITED KINGDOM;

EID: 84998179995     PISSN: 20451253     EISSN: 20451261     Source Type: Journal    
DOI: 10.1177/2045125312438215     Document Type: Article

References (23)

1. Addonizio G. Susman V.L. Roth S.D. (1986) Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. Am J Psychiatry 143: 1587–1590.
2. Adityanjee Mathews T. Aderibigbe Y. (1999) Proposed research diagnostic criteria for neuroleptic malignant syndrome. Int J Neuropsychopharmacol 2: 129–144.
3. Adityanjee Singh S. Singh G. Ong S. (1988) Spectrum concept of neuroleptic malignant syndrome. Br J Psychiatry 153: 107–111.
4. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington DC: American Psychiatric Association.
5. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders (4th ed., text revision). Washington DC: American Psychiatric Association.
6. Caroff S.N. Mann S.C. (1993) Neuroleptic malignant syndrome. Med Clin North Am 77: 185–202.
7. Caroff S.N. Mann S.C. Campbell E. (2000) Atypical antipsychotics and neuroleptic malignant syndrome. Psychiatr Ann 30: 314–321.
8. Caroff S. Mann S. Lazarus A. Sullican K. MacFadden W. (1991) Neuroleptic malignant syndrome: diagnostic issues. Psychiatr Ann 21: 130–147.
9. Friedman J.H. Davis R. Wagner R.L. (1988) Neuroleptic malignant syndrome: the results of a 6-month prospective study of incidence in a state psychiatric hospital. Clin Neuropharmacol 11: 373–377.
10. Gurrera R.J. Caroff S.N. Cohen A. Carroll B.T. DeRoos F. Francis A. et al. (2011) An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method. J Clin Psychiatry 72: 1222–1228.
11. Gurrera R.J. Chang S.S. Romero J.A. (1992) A comparison of diagnostic criteria for neuroleptic malignant syndrome. J Clin Psychiatry 53: 56–62.
12. Gurrera R.J. Simpson J.C. Tsuang M.T. (2007) Meta-analytic evidence of systematic bias in estimates of neuroleptic malignant syndrome incidence. Compr Psychiatry 48: 205–211.
13. Keck P.E. Pope H.G. Cohen B.M. McElroy S.L. Nierenberg A.A. (1989) Neuroleptic malignant syndrome risk factors for neuroleptic malignant syndrome: a case-control study. Arch Gen Psychiatry 46: 914–918.
14. Lazarus A. Mann S.C. Caroff S.N. (1989) The Neuroleptic Malignant Syndrome and Related Conditions. Washington DC: American Psychiatric Press.
15. Levenson J.L. (1985) Neuroleptic malignant syndrome. Am J Psychiatry 142: 185–185.
16. Levenson J.L. (1986) Reply to: Diagnosing and treating neuroleptic malignant syndrome. Am J Psychiatry 143: 675.
17. Margetić B. Aukst-Margetić B. (2010) Neuroleptic malignant syndrome and its controversies. Pharmacoepidemiol Drug Saf 19: 429–435.
18. Picard L.S. Lindsay S. Strawn J.R. Kaneria R.M. Patel N.C. Keck P.E. (2008) Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations. Pharmacotherapy 28: 530–535.
19. Pope H. Jr Keck P. Jr McElroy S. (1986) Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry 143: 1227–1233.
20. Sachdev P.S. (2005) A rating scale for neuroleptic malignant syndrome. Psychiatry Res 135: 249–256.
21. Stewart R. Soremekun M. Perera G. Broadbent M. Callard F. Denis M. et al. (2009) The South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register: development and descriptive data. BMC Psychiatry 9: 1–12.
22. Strawn J.R. Keck P.E. Caroff S.N. (2007) Neuroleptic malignant syndrome. Am J Psychiatry 164: 870–876.
23. Strawn J.R. Keck P.E. Caroff S.N. (2008) Current Psychiatry Online: Neuroleptic malignant syndrome: answers to 6 tough questions. Available at: http://www.jfponline.com/Pages.asp?AID=5810 (accessed 24 January 2012).